Morbidity and mortality in the antiretroviral era in sub-Saharan Africa: a systematic review protocol
Abstract Background Worldwide, Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome (HIV/AIDS) remains a public health problem. The prevalence of HIV in Sub-Saharan Africa is one of the uppermost in the world. Method/design Observational studies will be systematically reviewed reporting on morbidity and mortality in the antiretroviral therapy (ART) era in Sub-Saharan Africa. We will search relevant studies from the following databases: PubMed, Medline, CINAHL. Two review authors will independently screen titles abstracts and full text articles in duplicate, extract data and assess the bias. Discrepancies will be resolved by discussion or arbitration of a third review author. The study will use the Preferred Reporting Item of Systematic Review (PRISMA 2015) guideline. Discussion This review will summarise the determinants of morbidity and causes of mortality in the antiretroviral era in Sub-Saharan Africa. The findings of this study will help to improve opportunistic infection’s prevention and clinical outcomes in ART era. Systematic review registration PROSPERO CDR42019141933